Corona Remedies made a strong market debut on December 15, with shares listed at ₹1,461 on NSE and ₹1,452 on BSE, reflecting premiums of 37.57% and 36.72% respectively. The IPO was highly subscribed, achieving 144.54 times overall, with significant interest from institutional investors.
Source :- mint – markets Read More
